Observational study on quality of life, safety, and effectiveness of first‐line cetuximab plus chemotherapy in KRAS wild‐type metastatic colorectal cancer patients: the ObservEr Study

Cetuximab improves efficacy when added to chemotherapy for metastatic colorectal cancer (mCRC). Effective management of skin reactions from cetuximab improves quality of life (QoL), and treatment compliance in clinical trials. No data are available from real‐world settings. The ObservEr observationa...

Descripción completa

Detalles Bibliográficos
Autores principales: Pinto, Carmine, Di Fabio, Francesca, Rosati, Gerardo, Lolli, Ivan R., Ruggeri, Enzo M., Ciuffreda, Libero, Ferrari, Daris, Lo Re, Giovanni, Rosti, Giovanni, Tralongo, Paolo, Ferrara, Raimondo, Alabiso, Oscar, Chiara, Silvana, Ianniello, Giovanni P., Frassoldati, Antonio, Bilancia, Domenico, Campanella, Giovanna A., Signorelli, Carlo, Racca, Patrizia, Benincasa, Elena, Stroppolo, Maria Elena, Di Costanzo, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Cancer Prevention
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5119983/
https://www.ncbi.nlm.nih.gov/pubmed/27748041
http://dx.doi.org/10.1002/cam4.888

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5119983/
https://www.ncbi.nlm.nih.gov/pubmed/27748041
http://dx.doi.org/10.1002/cam4.888

Ejemplares similares